Literature DB >> 22736788

Understanding reversals of association between cancer screening and race/ethnicity.

William Rakowski1, Michelle L Rogers, Gregory M Dominick, Melissa A Clark.   

Abstract

BACKGROUND: We used a composite variable composed of insurance status, income, and race/ethnicity to investigate access-enhancing programs as a possible reason for "reversals of association" and large percent changes (LPC), between race/ethnicity and cancer screening, when comparing the unadjusted and adjusted ORs.
METHODS: Data were from women aged 40-64 years, using the combined 2008 and 2010 Behavioral Risk Factor Surveillance System surveys. Recent mammography was within the past 2 years, and recent Pap testing was within the past 3 years. Initial analyses using all variables singly were followed by analyses that used the composite variable with the remaining covariates.
RESULTS: Analyses with race/ethnicity singly indicated reversals of association for Hispanic women and higher estimated screening for black and Hispanic women than for white women. Analyses with the composite variable found no reversals of association, but there were several LPCs for Hispanic and black women, for lower income, and for uninsured women. White, uninsured, lower income women were among those with the lowest utilization.
CONCLUSIONS: Results were consistent with the possibility that access-enhancing programs for lower income, uninsured and often non-white women can lead to overestimates of screening, reversals of association, and LPCs in multivariable analyses. Attention should be given to identifying LPCs to unadjusted ORs. Lower income, uninsured, white women are also a group at risk of extremely low mammography and Pap test utilization. IMPACT: Combining variables to create better-targeted population subgroups may help in the interpretation of analyses that produce reversals of association and LPCs for correlates of cancer screening utilization. ©2012 AACR

Entities:  

Mesh:

Year:  2012        PMID: 22736788      PMCID: PMC3815614          DOI: 10.1158/1055-9965.EPI-11-1223

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  6 in total

1.  Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team.

Authors:  Ali H Mokdad; Donna F Stroup; Wayne H Giles
Journal:  MMWR Recomm Rep       Date:  2003-05-23

Review 2.  Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2010 Mar-Apr       Impact factor: 508.702

3.  Smoking status and mammography among women aged 50-75 in the 2002 behavioral risk factor surveillance system.

Authors:  William Rakowski; Melissa A Clark; Rachel Truchil; Karen Schneider; Stephen Meersman
Journal:  Women Health       Date:  2005

4.  Reversals of association for Pap, colorectal, and prostate cancer testing among Hispanic and non-Hispanic black women and men.

Authors:  William Rakowski; Melissa A Clark; Michelle L Rogers; Sherry H Weitzen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-10       Impact factor: 4.254

5.  Investigating reversals of association for utilization of recent mammography among Hispanic and Non-Hispanic Black women.

Authors:  William Rakowski; Melissa A Clark; Michelle L Rogers; Sherry Weitzen
Journal:  Cancer Causes Control       Date:  2009-04-26       Impact factor: 2.506

6.  Breast cancer screening and ethnicity in the United States: implications for health disparities research.

Authors:  Patricia Y Miranda; Wassim Tarraf; Hector M González
Journal:  Breast Cancer Res Treat       Date:  2011-02-06       Impact factor: 4.872

  6 in total
  1 in total

1.  Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties.

Authors:  Mandeep K Virk-Baker; Michelle Y Martin; Robert S Levine; Xin Wang; Tim R Nagy; Maria Pisu
Journal:  Cancer Causes Control       Date:  2013-12       Impact factor: 2.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.